Primary FDA-Approved Indications
It is guideline-supported for giardiasis, bacterial vaginosis, trichomoniasis, and adjunctive therapy in anaerobic abscesses and C. difficile infection.
Giardiasis
FDA ApprovedChildrenRandomized trials
Evidence Sources
()
Bacterial vaginosis
FDA ApprovedAdolescentsCDC STI guideline
Evidence Sources
()
Anaerobic intra-abdominal infection
FDA ApprovedChildrenIDSA guideline
Evidence Sources
()